About
기업개요
CEO 인사말
리더십
연혁
비전 & 미션
Technology
Dual Action Therapy (DAT) Platform
Pipeline
파이프라인 스케줄
Clinical Trials
Clinical Trials
PR/IR
공지사항
연구성과
Contact
Career
Contact Us
찾아오시는 길
언어선택
KOR
ENG
About
기업개요
CEO 인사말
리더십
연혁
비전 & 미션
Technology
Dual Action Therapy (DAT) Platform
Pipeline
파이프라인 스케줄
Clinical Trials
Clinical Trials
PR/IR
공지사항
연구성과
Contact
Career
Contact Us
찾아오시는 길
PR
/
IR
연구성과
PR
/
IR
SCROLL
공지사항
연구성과
연구성과
PAPER
Hyperphosphorylated tau targeting human serum albumin Fusion protein as therapeutics for Alzheimer&r..
12.09.2024
PATENT
Methods of decreasing amyloid beta (Aβ) plaque deposition and hyperphosphorylated tau plaque de..
10.24.2024
PAPER
Human serum albumin fusion protein as therapeutics for targeting amyloid beta in Alzheimer’s d..
01.22.2022
PATENT
Method for Treating Shingles with N-Methanocarbathymidine (N-MCT)
08.01.2018
1